TCL’s Note A1 NXTPAPER Is An Excellent Device For Handwriting And Drawing

The tablet, which offers a screen that resembles an e-ink display, is designed to be a productivity tool.

This CEO’s $1.7 Billion Health Startup Began With Moms. Now She Wants To Expand To All Women.

Former Flatiron Health exec Marta Bralic Kerns raised $92 million to expand her virtual care model to women at all stages of their lives.

Chinese OpenAI Challenger Zhipu’s IPO Mints New Billionaire

Zhipu, which operates a ChatGPT-like service called Z.ai, raised $558 million in the IPO. Its chairman, Liu Debing, amassed a fortune of $2.1 billion based on his stake in the Chinese AI model company.

Measles And Flu Hit New Highs As Trump Administration Hammers Vaccines

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s weight-loss pill, and more.

Tesla’s Manufacturing Hangover Is Steering Musk Into Robotics

The electric vehicle maker used just 70% of its plant capacity last year – a level comparable to traditional auto rivals. Things could get worse in 2026.

These Lesser Known AI Stocks Are Reaching Record Highs

After a decade of modest gains, data storage companies like Sandisk, Seagate and Western Digital had a stunning run in 2025.

Good Day Sunshine: Solar’s Relentless Rise

This week’s Current Climate newsletter also looks at Elon Musk’s year of big blunders and payday bonanzas and some progress for green hydrogen

From The ‘School Of Elon Musk’ To Billion-Dollar Startups: Meet SpaceX’s Alumni Founders

Former SpaceX propulsion CTO Thomas Mueller’s space startup reached unicorn status this year thanks to $525 million in funding since 2021. It’s just one of 141 other startups founded by SpaceX alumni.

How Portable Power Leader Jackery Is Helping Americans Gain Energy Independence

At Consumer Electronics Show (CES) 2026, Jackery is introducing a series of products to help Americans power their homes without relying on the traditional grid.

How A Wall Street Analyst Started A $4 Billion Obesity Drug Company

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.